Related Experiment Video
Updated: May 6, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Chemically induced cardiotoxicity: Role of voltage dependent ion channels
Diego Jose Belato Orts1, Aimée Obolari Durço1, Michael Ramon de Lima Conceição1
1Department of Biophyscis, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
Abstract:
Chemicals pervade human environments, with> 350,000 synthetic compounds driving unintentional exposures and pollution-linked deaths exceeding those from infectious diseases or violence. This review discusses the mechanisms of chemically induced cardiotoxicity (including pesticides, pollutants, heavy metals, and chemotherapeutics), emphasizing modulation of voltage-gated ion channels in cardiomyocytes, which disrupts action potential (AP) dynamics, excitation-contraction coupling (ECC), and predisposes to arrhythmogenesis. Key currents, sodium (INa), calcium (ICaL, ICaT), and potassium (Ito, IKr, IK1), are differentially altered. Pyrethroid pesticides (e.g., deltamethrin) amplify late INa, prolong AP, and trigger afterdepolarizations. Organochlorines (e.g., aldrin) suppress peak INa; organophosphates, carbamates, and fungicides (e.g., tebuconazole) inhibit ICaL, INa, and K+ currents, often via oxidative stress. Glyphosate-based herbicides impair ICaL; rodenticides (e.g., phosphides) block K+ hERG channel, mimicking Brugada syndrome. Environmental pollutants lack direct ion-channel block properties evidence but provoke arrhythmias via inflammation/fibrosis (diesel exhaust), NO/redox inhibition (CO: INa, hERG, Kir), current enhancement (SO2: INa, Ito, ICaL), or ROS-CaMKII activation (particulate matter). Heavy metals attenuates channels class-specifically: Pb2+ (ICaL), Ni2+ (ICaT), Cd2+ (INa, ICaL), Hg2+ (Ito, ICaL); Se/Zn modulate K+/Ca2+ currents in deficiency/excess. Chemotherapeutics exacerbate cardiovascular risk: anthracyclines (e.g., doxorubicin) boost ICaL and RyR2 leak; platinums delay INa decay; TKIs (e.g., ibrutinib) broadly suppress currents kinase-dependently. Integrating in vitro/experimental molecular data, this review maps class-specific electrophysiological impacts in the heart, highlighting safety pharmacology's role in risk mitigation and informing therapeutic, regulatory, and public health strategies to safeguard cardiovascular resilience against pervasive chemical threats.
More Related Videos
11:32Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Cellular Injury IV: Necrosis
Heart Failure Drugs: Inotropic Agents
Mechanism of Cardiac Arrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials